Abstract 978: Synergistic activity of EP-100 and chemotherapies in cancer cell lines.

长春瑞滨 紫杉醇 阿霉素 长春新碱 药理学 医学 联合化疗 癌症 顺铂 癌症研究 化疗 内科学 环磷酰胺
作者
Carola Leuschner,Shashi Gavini,Hector W. Alila
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:73 (8_Supplement): 978-978 被引量:2
标识
DOI:10.1158/1538-7445.am2013-978
摘要

Abstract EP-100, a targeted anti-cancer drug comprised of a lytic peptide fused to Luteinizing Hormone Releasing Hormone (LHRH), is in Phase 2 clinical trial in tumors that over-express LHRH receptors in combination with paclitaxel. It kills cancer cells by membrane disruption. EP-100 was tested in combination with paclitaxel, vinorelbine, doxorubicin, cisplatinum, vincristine and 5 fluorouracil (5FU) in vitro. The sequence of adding EP-100 to the chemotherapeutics was tested in consideration of their half-lives (hours) than EP-100 (minutes). EP-100 was added to the cells before or after treatment with the chemotherapeutics to determine the order of treatment for maximum synergy. Cells were cultured in the presence of each single agent and in combination with EP-100 for 72h. Data were analyzed as IC50 values for each single drug and the combination with EP-100. Combination indices (CI) on interaction of EP-100 and each chemotherapeutic were determined. EP-100 alone was cytotoxic at low uM concentrations in LHRH receptor (+), multi-drug resistant human uterine sarcoma cell line MES-SA-Dx5 and a human breast cancer cell line MDA-MB-231 after 72 h incubation. Both cell lines were resistant to paclitaxel, vinorelbine, vincristine, 5-FU and cisplatinum. MES-SA-Dx5 cells were resistant to doxorubicin. Addition of EP-100 to each of the chemotherapeutics increased sensitivity to all of the drugs except 5-FU (Table 1). Combinations of EP-100 with paclitaxel, vincristine, vinorelbine, doxorubicin and cisplatinum resulted in potentiation of activity in a synergistic manner for both uterine sarcoma and breast cancer cell lines. The combination effects were synergistic with CIs of 0.2. The sequence of exposure was most potent when EP-100 was given first followed by incubation with paclitaxel, doxorubicin or vinorelbine. Table 1 In vitro activities (IC50 - nM) MES-SA-Dx5 Combination Index Potentiation MDA-MB-231 Combination Index Potentiation EP-100 Alone 3044 ± 558 1400 ± 300 Paclitaxel 33.7 ± 2.2 86.2 ± 5.9 EP100+Paclitaxel 0.014 ± 0.002 0.001 6000 15.9 ± 0.8 0.22 5.7 Vincristine 124.7 ± 16.3 26.3 ± 4.1 EP-100+Vincristine 5.7 ± 0.9 0.02 21.7 1.8 ± 0.1 0.09 15 Doxorubicin 32.6 ± 4.3 1.26 ± 0.4 EP-100+Doxorubicin 3.3 ± 0.6 0.09 9.6 1.1 ± 0.04 NA 1 Vinorelbine 63.22 ± 15.9 23.7 ± 3.4 EP-100+Vinorelbine 6.0 ± 1.6 0.06 10.5 3.1 ± 0.9 0.1 7.6 CDDP 54.5 ± 5.8 19.9 ± 6.2 EP-100 + CDDP 8.0 ± 2.6 0.2 6.8 8.1 ± 1.9 0.1 2.5 These results indicate that EP-100 synergizes with paclitaxel, doxorubicin, vinorelbine, vincristine and cisplatinum but not 5-FU in drug resistant human uterine sarcoma and breast cancer cells. Citation Format: Carola Leuschner, Shashi Gavini, Hector W. Alila. Synergistic activity of EP-100 and chemotherapies in cancer cell lines. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 978. doi:10.1158/1538-7445.AM2013-978

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
秀丽笑容完成签到 ,获得积分10
3秒前
江湖应助聪慧芷巧采纳,获得10
4秒前
量子星尘发布了新的文献求助10
5秒前
Rjy完成签到 ,获得积分10
11秒前
性感母蟑螂完成签到 ,获得积分10
17秒前
ruochenzu完成签到,获得积分10
19秒前
陈尹蓝完成签到 ,获得积分10
20秒前
天道酬勤完成签到,获得积分10
22秒前
24秒前
仁爱的谷南完成签到,获得积分10
24秒前
雯雯完成签到 ,获得积分10
26秒前
一路有你完成签到 ,获得积分10
26秒前
27秒前
ruochenzu发布了新的文献求助10
27秒前
29秒前
wanghao完成签到 ,获得积分10
30秒前
图图发布了新的文献求助10
30秒前
十三完成签到 ,获得积分10
30秒前
聪慧芷巧完成签到,获得积分10
31秒前
米博士完成签到,获得积分10
32秒前
研友_VZGVzn完成签到,获得积分10
33秒前
Cheung2121发布了新的文献求助30
34秒前
黄芩完成签到 ,获得积分10
35秒前
52秒前
秋半梦完成签到,获得积分10
54秒前
李爱国应助科研通管家采纳,获得10
57秒前
科研通AI2S应助科研通管家采纳,获得10
57秒前
搜集达人应助科研通管家采纳,获得10
57秒前
打地鼠工人完成签到,获得积分10
58秒前
彩色半烟完成签到,获得积分10
1分钟前
量子星尘发布了新的文献求助10
1分钟前
Ning完成签到,获得积分10
1分钟前
图图完成签到,获得积分10
1分钟前
勤奋的灯完成签到 ,获得积分10
1分钟前
ludong_0完成签到,获得积分10
1分钟前
Asumita完成签到,获得积分10
1分钟前
双青豆完成签到 ,获得积分10
1分钟前
1分钟前
fxy完成签到 ,获得积分10
1分钟前
合适的幻然完成签到,获得积分10
1分钟前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038066
求助须知:如何正确求助?哪些是违规求助? 3575779
关于积分的说明 11373801
捐赠科研通 3305584
什么是DOI,文献DOI怎么找? 1819239
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022